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SUMMARY
The transcytosis of antigens across the gut epithelium by microfold cells (M cells) is important for
the induction of efficient immune responses to some mucosal antigens in Peyer’s patches.
Recently, substantial progress has been made in our understanding of the factors that influence the
development and function of M cells. This review highlights these important advances, with
particular emphasis on: the host genes which control the functional maturation of M cells; how
this knowledge has led to the rapid advance in our understanding of M-cell biology in the steady-
state and during aging; molecules expressed on M cells which appear to be used as
“immunosurveillance” receptors to sample pathogenic microorganisms in the gut; how certain
pathogens appear to exploit M cells to infect the host; and finally how this knowledge has been
used to specifically target antigens to M cells to attempt to improve the efficacy of mucosal
vaccines.
INTRODUCTION
A single layer of epithelial cells provides a protective barrier against the substantial bacterial
burden within the intestinal lumen. However, the epithelia overlying the organized lymphoid
follicles of the gut-associated lymphoid tissues (GALT) including the Peyer’s patches, their
equivalents in the caecum and colon, and isolated lymphoid follicles (ILFs), are specialized
for sampling the lumenal contents. Under steady-state conditions approximately 10 % of the
epithelial cells within these follicle-associated epithelia (FAE) are microfold (M) cells1-3.
These cells have unique morphological features including the presence of a reduced
glycocalyx, irregular brush border and reduced microvilli. Furthermore, in contrast to the
neighbouring enterocytes within the FAE, M cells are highly specialized for the
phagocytosis and transcytosis of gut lumen macromolecules, particulate antigens and
pathogenic or commensal microorganisms across epithelium (Figure 1). Following their
transcytosis across the FAE, antigens exit into the intraepithelial pocket beneath the M-cell
basolateral membrane which contains various populations of lymphocytes and mononuclear
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phagocytes (MNP, a heterogenous population of macrophages and classical dendritic
cells4-6). This specialized microenvironment beneath the M-cell enables the efficient transfer
of lumenal antigens to MNP7, 8. Studies show that in the absence of M cells, or antigen
sampling by M cells, antigen-specific T-cell responses in the Peyer’s patches of mice orally-
infected with Salmonella enterica serovar Typhimurium are reduced2, 9. Thus, the efficient
M-cell-mediated sampling of gut lumenal antigens is considered an important initial step in
the induction of some mucosal immune responses2, 7-9.
In this review we mostly describe the recent progress that has been made in our
understanding of the immunobiology of M cells in the intestine, but it is important to note
that M cells are not only restricted the FAE overlying the GALT. For example, cells with
typical features of M cells have been reported in the murine nasal passage epithelium,
identifying a novel, NALT-independent mode of antigen sampling in the respiratory tract10.
In the intestine M cells have also been described within the villous epithelium8, 11,12, but
whether these cells are functionally equivalent to those within the FAE overlying the
organised lymphoid follicles remains to be determined13.
M cells differentiate from Lgr5+ stem cells in the crypts in a RANKL- and Spi-B dependent
manner
Since M cells are considered to play an important role in the induction of specific mucosal
immune responses in the Peyer’s patches2, 9, their manipulation may improve the efficacy of
mucosal vaccines or help develop strategies to block transmission of some orally-acquired
infections (discussed below). Many studies have therefore attempted to elucidate the
molecular mechanisms which regulate M-cell differentiation in the gut epithelium. In the
intestine almost all epithelial cell lineages develop from intestinal epithelial stem cells
within the crypts. The dome-associated crypts surrounding the FAE, and the villous crypts at
the base of the villi, each contain cycling leucine-rich repeat-containing G protein-coupled
receptor-(Lgr5-) positive+ stem cells intermingled amongst Paneth cells14. These stem cells
produce highly proliferative daughter cells which upon appropriate stimulation can
differentiate into all the epithelial cell populations within the small intestine including the
enterocytes, goblet cells, enteroendocrine cells, tuft cells and Paneth cells. Lineage-tracing
studies using transgenic mice expressing a reporter gene (LacZ) under control of the Lgr5
promoter have confirmed that all the epithelial cells within the FAE, including M cells, are
derived from the cycling Lgr5+ stem cells within the dome-associated crypts15-17 (Figure 2).
In the mouse intestine under steady-state conditions M cells are mostly confined to the FAE
overlying the organized lymphoid follicles of the GALT. Since both the dome-associated
crypts and the villous crypts throughout the intestine contain cycling Lgr5+ stem cells,
additional signals from the cells beneath the FAE in the subepithelial dome (SED) are
required to induce M-cell differentiation, and in doing so restrict these cells to the epithelia
overlying organized lymphoid follicles. The TNF superfamily member receptor activator of
NF-κB ligand (RANKL), signals via its receptor RANK (receptor activator of NF-κB),
which is expressed by epithelial cells throughout the intestine. However, in the intestine
RANKL is selectively expressed by the subepithelial stromal cells beneath the FAE18, 19.
Analysis of RANKL-deficient mice, and administration of exogenous RANKL in vivo,
show this cytokine is a critical factor that controls the differentiation of RANK-expressing
enterocytes into M cells20. Under steady-state conditions, the only RANK-expressing
intestinal epithelial cells that are exposed to sufficient RANKL from any source to respond
in a detectable way are those in the FAE that are immediately above the RANKL-expressing
subepithelial stromal cells. These data imply that in the context of M-cell differentiation,
much of the RANKL-RANK signalling is delivered by the intact transmembrane cytokine
following direct cell contact, rather than systemic dissemination of soluble RANKL.
However, the possibility cannot be entirely excluded that both the membrane and soluble
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forms of RANKL are expressed by SED stromal cells. Accordingly, in the steady state,
villous enterocytes situated distant from organized lymphoid structures are not exposed to
enough RANKL to show any induction of the genes that regulate M cell-differentiation2, 20.
Thus, the restriction of RANKL-expression to the subepithelial stromal cells ensures that the
differentiation of Lgr5+ stem cells into M cells is spatially restricted to the FAE overlying
GALT (Figure 2). Consistent with this theory, the systemic treatment of mice with RANKL
induces the ectopic differentiation of enterocytes into M cells in the villous epithelium2, 20.
To help to focus the effects of soluble RANKL to the overlying FAE, it is plausible that the
range of its activity is further restricted by binding to osteoprotegerin, a secreted decoy
receptor of RANKL21.
Distinct transcription factors control the expression of the sets of genes which ultimately
determine the differentiation of crypt stem cell-derived progenitor cells into terminally
differentiated intestinal epithelial cell populations. The same is true for M cells. The
RANKL-induced, M cell-intrinsic, expression of the ETS transcription factor Spi-B
specifically regulates the maturation of immature M cells into functionally mature M cells.
While immature M-cell differentiation appeared to be unaffected in Spi-B-deficient (Spi-
B−/−) mice, their FAE were are almost completely deficient in functionally mature M
cells2, 15, 22. Thus, the terminal differentiation of M cells, as for other intestinal epithelial
cell lineages, is regulated by a specific transcription factor (Figure 2).
Transcriptomic profiling studies have helped to identify those genes which are expressed by
functionally mature M cells and regulated by Spi-B, including: Gp2, Tnfaip2 and Ccl9
(discussed below). Others such as Anxa5 and Marcksl1 (which encode for annexin A5 and
MARCKS-like protein 1, respectively) are expressed by immature (differentiating) M cells
in response to RANKL-stimulation but are regulated independently of Spi-B2, 13, 15, 23-26.
Although their precise roles are uncertain, the immature M-cell markers such as ANXA5
and MARCKS-like protein 1 may be involved in cytoskeletal regulation to help adapt the
differentiating epithelial cell towards one specialized for transcytosis27, 28.
An independent study has also investigated the requirement for Spi-B in M-cell
differentiation22. In this study two distinct monoclonal Abs were used to detect M cells: one
mAb specific for glycoprotein 2 (GP2, discussed below); and mAb NKM 16-2-4 which
specifically recognises sites of α-1,2 fucosylation25, 29 and has a greater degree of
specificity for M cells than the lectin Ulex europaeus agglutinin I (UEA-1, which also binds
α-1,2 fucose with high-affinity). While the expression of the mature GP2+ M cells was
completely absent in the FAE of Spi-B−/− mice, a small number of mAb NKM 16-2-4+ M
cells were evident (~10 mAb NKM 16-2-4+ M cells/FAE)22. One interpretation of these
apparently contradictory data is that a small population of M cells in the FAE may mature
independently of Spi-B and as a consequence do not express proteins such as GP2 on their
surfaces22. Alternatively, it is plausible that the remaining mAb NKM 16-2-4+ cells in the
FAE of Spi-B−/− mice were not fully differentiated M cells, or represented other populations
of fucosylated enterocytes.
M cells appear to be regularly spaced in the FAE implying that their distribution is highly
regulated (Figure 1b). Indeed, while all the epithelial cells in the FAE derive from Lgr5+
stem cells15 and are exposed to high levels of RANKL-stimulation from the stromal cells in
the SED20, only a proportion of the cells are destined to become M cells. Hsieh and
colleagues have questioned how this distribution may be regulated30. Notch receptors and
their ligands play important roles in determining cell fate and tissue patterning. For example,
direct cell-cell signalling, where the expression of a Notch ligand by one cell, may influence
the fate of an adjacent cell expressing a Notch receptor. Consistent with this role, Notch and
the ligand Jagged1 also appear to influence the patterning of M cells across the FAE30. The
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optimal distribution of M cells across the FAE may be important to ensure efficient immune
surveillance, while at the same time maintaining the integrity of the FAE.
Analysis of cleaved caspase-3 expression in the intestinal epithelia of rats suggested that
almost all the epithelial cells within the villi appear to be undergoing apoptosis, whereas the
onset of apoptosis within the FAE has been reported to be delayed31. The differentiation and
maturation of M cells from Lgr5+ stem cells within the crypts takes ~3-4 days2, 20. Whether
this apparent delay to the progression of apoptosis in the FAE enables M-cell differentiation
to be sustained for longer periods is uncertain.
Lympho-epithelial factors influence M cell differentiation in the FAE
In addition to the important stimuli provided to the differentiating M cells in the FAE by
SED stromal cells, lympho-epithelial cell interactions also influence their development.
Indeed, a role for haematopoietic cells such as B cells in inducing M-cell differentiation is
well established32, 33. In the small intestine the chemokine CCL20 is specifically expressed
by the FAE34, and in Peyer’s patches it mediates the chemoattraction of CCR6-expressing
lymphocytes and leukocytes towards the FAE35. Mice deficient in CCR6 (CCR6−/− mice),
the sole receptor for CCL20, have a significantly reduced frequency of mature GP2+ M cells
in the FAE36-38, implying that the impaired migration of CCR6-expressing lymphocytes or
leukocytes towards the FAE impedes M cell differentiation due to reduced lympho-epithelial
cell interactions. Alternatively, this may also be due to an altered cytokine milieu in the
SED. In the Peyer’s patches a unique subset of CCR6hiCD11cint B cells has been reported to
specifically migrate towards FAE-derived CCL20 and promote M-cell differentiation37
(Figure 2). In the absence of CCR6 these cells could not migrate towards the FAE and M-
cell differentiation was impeded, whereas their transfer into CCR6−/− mice coincided with
restored M-cell maturation. Further analysis shows that although mature M cells are
dramatically reduced in the FAE of CCR6−/− mice, immature ANXA5-expressing M cells
are retained36-38. These data imply that CCL20-CCR6-signaling blockade in CCR6−/− mice
does not impact on the initial induction of M-cell differentiation, but specifically impedes
their functional maturation. Enteroinvasive bacteria including S. Typhimurium and the
pathogenic bacteria S. Enteritidis and Listeria monocytogenes39 have each been shown to
induce CCL20 expression by intestinal epithelial cells. This pathogen-mediated stimulation
of CCL20 expression may be part of the host’s response to infection to attempt to enhance
the “immunosurveillance” of the gut lumen. Alternatively, these pathogens may exploit this
potentially aid their uptake from the gut lumen by stimulating the differentiation of
enterocytes into M cells.
The factors provided by B cells (or other haematopoietic cell populations) that stimulate M-
cell differentiation are uncertain, but may involve signalling between B cells and the M cell
progenitor cells via CD137L/CD1378, 40 or macrophage migration inhibitory factor41. The
expression of CCL20 in the intestinal epithelium is rapidly induced by RANKL-stimulation
(Figure 3) and enhanced by TNFR and LTβR stimulation2, 42-44. However, haematopoietic
cell populations within Peyer’s patches, including the CD11c+ B cells, do not express
RANKL37, and B cell-derived TNF and lymphotoxin are each dispensable for the
development of the FAE and M cells45. While the above studies together provide a plausible
model by which lympho-epithelial interactions may contribute to the functional maturation
of M cells, it is important to note that M cell maturation can be induced in an in vitro “gut
organoid” model system which contains only epithelial cell elements15. Although the in vivo
environment may differ significantly from that of an in vitro gut organoid, these data suggest
that these lympho-epithelial interactions most likely provide accessory factors that enhance
M-cell differentiation (Figure 2).
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M cells are equipped with an array of molecules to sample lumenal antigens
M cells provide an efficient portal through which gut lumenal antigens can be delivered to
the underlying mucosal lymphoid tissues. In order to achieve this, M cells in contrast to
enterocytes, have a high endocytic and transcytotic capacity. Whether the sampling and
transcytosis of microoganisms/antigens by M cells occurs predominantly in a non-selective
manner as a consequence of constitutive “bulk sampling” of the lumenal contents,
specifically via receptor mediated endocytosis, or both is uncertain. However, data from
many studies suggest that M cells express a variety of “immunosurveillance” receptors on
their apical surfaces which enable them to sample a diverse range of microbial pathogens
and antigens.
Glycoprotein 2—Independent sets of gene profiling experiments aimed at identifying
molecules that were expressed highly by M cells, but not by other enterocyte populations,
identified GP2 as a specific M-cell marker24, 25. This GPI-anchored protein is highly
expressed on the apical surface of M cells and selectively binds to the FimH component of
the type I pili on the outer membrane of certain pathogenic and commensal bacteria such as
Eschericia coli and S. Typhmurium. In the absence of GP2 expression by M cells, the
transcytosis of type-I-piliated bacteria was impeded9. Furthermore, GP2-dependent bacterial
transcytosis by M cells was shown to be important for the immunosurveillance of FimH+
bacteria in the gut lumen9.
Uromodulin—A homolog of GP2, uromodulin (UMOD or Tamm-Horsfall protein, THP),
has also been reported to be specifically expressed by M cells15, 22. Secreted UMOD is a
urinary protein which can also bind specifically to type-I-piliated E. coli and may function to
prevent these bacteria from binding to uroepithelial cells46. Although the expression of
Umod by Peyer’s patch M cells is much lower than Gp2 their similar characteristics imply
that each protein may aid the sampling of FimH+ bacteria in the gut lumen9, 22.
Cellular prion protein—Continuing with the immunosurveillance theme, the cellular
prion protein (PrPC) is also expressed highly on the apical membrane of M cells26 and has
been implicated in the sampling of microorganisms from the gut lumen47. The GPI-
anchored PrPC protein is expressed highly by many cell populations in mammals, but its
precise function remains uncertain as PrP-deficient mice do not show an obvious phenotype.
The Gram-negative bacterium Brucella abortus is a facultative intracellular pathogen and
can express the heat shock protein 60 (Hsp60) on its cell surface. Data show that PrPC can
interact with Hsp60, and may play an important role in the binding and internalization of B.
abortus into M cells47. Thus, PrPC may also act as an uptake receptor for pathogenic bacteria
which express Hsp60.
Other M-cell-specific proteins—A number of other M-cell-specific proteins have been
reported which may similarly selectively bind to components of potentially pathogenic
microorganisms. However, experiments are required to determine their in vivo functions in
M cells. ANXA5 is expressed by immature and mature M cells48, and can bind to Gram-
negative bacteria with high affinity via the lipid A domain of LPS49. The endotoxin activity
of LPS is blocked when bound to ANXA5 implying an important anti-inflammatory role to
protect the host against LPS-mediated endotoxemia. Alternatively, it is plausible that
ANXA5 on M cells by binding LPS acts as an uptake receptor for Gram-negative bacteria.
However, further studies are necessary to determine whether the lipid A domain of LPS
would be directly accessible to M-cell-associated membrane receptors, or whether lipid A
only becomes accessible after bacterial degradation. Peptidoglycan recognition protein
(PGLRP)-1 (encoded by Pglyrp1, also known as PGRP-S) is an innate pattern recognition
protein that binds to bacterial peptidoglycan, and is expressed highly by M cells8. Little is
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known of the in vivo functions of the four mammalian PGLRPs, but PGLRP1 has
bactericidal activity against Gram-positive bacteria and is not known to be involved in cell-
signalling50. Whether the PGLRP1 secreted by M cells exhibits a similar bactericidal
activity to help protect the host against internalized bacteria remains to be determined? The
potential roles of other M-cell expressed proteins are less discernible such as fatty acid
binding protein 551, clusterin52 and secretogranin V (encoded by Scg5, also known as
Sgne-1)24.
A phage-display screen of potential M-cell ligands identified one peptide, termed “Co1”,
which shared high sequence homology with the α1 helix of the outer membrane protein H
(OmpH) of Yersinia enterocolitica53. The same region of OmpH is also homologous to that
of an E. coli chaperone protein, Skp, which can act as a complement C5a receptor (C5aR)
chemotactic ligand. Data from the combined analysis of an in vitro M-cell-like model and
mouse Peyer’s patch M cells in vivo, have suggested that OmpH β1α1 binds to C5aR on the
apical M-cell surface and enhances the transcytosis of antigens into M cells54. However,
whether direct molecular interactions between OmpH β1α1 and C5aR (and homologous
ligands) occur on M cells is uncertain.
Secretory IgA—Secretory IgA provides a first line of defence in the mucosal immune
system by preventing the access of specific pathogens and their toxins across the intestinal
epithelium, and is an important regulator of the composition of the commensal gut
microflora55. For example, secretory IgA is essential for protection from the effects of
lumenal cholera toxin exposure56. Secretory IgA can block lumenal pathogens from binding
to gut epithelial cells and in doing so can provide protection against intestinal reovirus
infection57. Similarly, secretory IgA may also mediate the lumenal trapping of certain
bacteria such as Shigella flexneri retaining them within the mucus layer overlying the
intestinal epithelium58. Prevention of infection against oral infection with S. typhimurium
has also been described59. The targeting of secretory IgA-containing immune-complexes to
M cells appears to lead to their subsequent transcytosis through to the MNP and
lymphocytes in the SED60, 61. Thus, in addition to the role of secretory IgA in facilitating
the immune-exclusion of lumenal pathogens and their antigens, the transcytosis of IgA by M
cells may also aid antigen sampling and modulate mucosal immune responses. Whether the
binding and uptake of secretory IgA and/or IgA-containing immune complexes by M cells
occurs specifically is uncertain. No putative IgA receptor has been reported to be expressed
by M cells. The possibility therefore cannot be excluded that the enhanced pinocytic and
transcytotic activity of M cells alone is sufficient to efficiently internalize secretory IgA and/
or IgA-containing immune complexes. Following their uptake from the gut lumen IgA-
containing immune-complexes do not appear to disseminate beyond the mesenteric lymph
nodes61. It is plausible that the secretory IgA-mediated, selective delivery of potential gut
pathogens to Peyer’s patches, may act to enable antigen recognition under neutralizing and
non-inflammatory conditions without causing widespread tissue dissemination.
Attraction to, and communication with, immune cells in the basolateral pocket
The M-cell basolateral pocket is a specialized microenvironment beneath the FAE which
enables close interactions between M cells, MNP, B cells and T cells7, 8. These cellular
associations ensure that transcytosed microorganisms or macromolecules are readily
acquired by specific immune cell populations to induce an appropriate immune response. M
cells may even establish intercellular communication channels in order to transport cellular
components between themselves and the cells within the basolateral pocket62. Tunneling
nanotubes (TNT) are thin membranous intercellular conduits which enable the transport of
cellular components between cells. Pathogens may also exploit these TNT conduits to aid
their dissemination between host cells63, 64 or to manipulate the host’s response to infection
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by shuttling pathogen-derived immunosuppressive factors from infected cells to immune
cell populations65. Tumour necrosis factor alpha-induced protein 2 (TNFAIP2, also known
as M-Sec) is expressed specifically by mature M cells in a Spi-B-dependent manner2, 24. In
Peyer’s patches TNFAIP2 is associated with TNT-like structures which appear to
interconnect the M cells in the FAE62. Data show that TNFAIP2 acts as a key regulator of
TNT formation between immune cells. Thus, the close association of M cells with MNP
raises the possibility that some microorganisms or macromolecules may be directly
transferred from the gut lumen to MNP via M-cell-derived TNT.
Chemokines and chemokine receptors play important roles in attracting lymphocytes and
leukocytes to lymphoid tissues and controlling their positioning within them. In addition to
CCL2034, several other chemokines are also expressed by the FAE, some of them
specifically by M cells including CCL92, 25, 66 and CXCL1625, 67 (Figure 3). Retrospective
analysis of the magnitude of all the chemokine encoding genes expressed by microarray data
sets derived from Peyer’s patch M cells25, the FAE26 and RANKL-stimulated villous
epithelia2 also indicates significant expression of CXCL11 when compared to the small
intestine villous epithelium. The detection of a specific set of chemokines implies their
expression is regulated by an underlying transcriptional program.
The wide range of chemokines and receptors expressed in mammals can lead to redundancy
whereby several chemokines may bind and activate certain chemokine receptors. However,
despite this apparent redundancy, mice deficient in the sole receptor for CCL20 (CCR6−/−
mice) show a significant deficiency in M-cell maturation in the FAE36, 37. These data
suggest that the other FAE- and M-cell-expressed chemokines most likely have accessory
roles, such as the attraction of specific cell populations to the basolateral pocket to sample
antigens and mount an immune response. The chemokine CCL9 appears to be preferentially
expressed by mature M cells and may aid the recruitment of CD11b+ MNP to the SED of
Peyer’s patches2, 66. CXCL16 expression may promote interactions between the FAE and
CXCR6-expressing T cells67, and may plausibly also act as an antimicrobial peptide in the
mucosal epithelium68. CCL25 expression may help mediate the homing of IgA antibody-
secreting cells69, whereas CXCL11 may stimulate the attraction of CXCR3-expressing Th1
cells70.
Pathogens can exploit M cells to invade the host
Pathogenic microorganisms have evolved a wide range of mechanisms to evade or even
exploit immune cells to infect the host. M cells are no exception to this as their efficient
transcytotic activity is exploited by numerous pathogens to breach the gut epithelium. In the
absence of M cells, oral infections with Y. enterocolitica36, prions71 or retrovirus33 are
blocked or impeded. A role for M cells as portals for the entry of Listeria monocytogenes72,
Mycobacterium avium subsp. paratuberculosis73, 74, S. Typhimurium75, human
immunodeficiency virus type 176, influenza virus77, polio virus78 and reovirus79 have also
been described. Staphylococcus aureus secretes a number of virulence factors such as the
enterotoxins which can help subvert the host immune system. Data from in vitro studies
imply that M cells may also aid the passage of staphylococcal enterotoxin A across the gut
epithelium80. Together, these examples show that whereas the sampling of intestinal
bacteria by M cells may be important for the induction of specific immunity in Peyer’s
patches, this function has the potential to be a critical Achilles heel by enabling the safe
passage of some pathogenic microorganism or their toxins across mucosal epithelia.
Pathogens can manipulate M cells to invade the host
While some pathogenic microorganisms may use molecules expressed on the apical surfaces
M cells as invasion receptors to infect the host, others appear to have evolved mechanisms
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that exploit the plasticity of enterocytes to specifically induce M-cell differentiation in the
gut epithelium. For example, apparent increases in M-cell-density or antigen transcytosis in
the FAE have been described following exposure to S. Typhimurium81 and Streptococcus
pneumoniae R36a82, 83.
The RANKL- and Spi-B-dependent differentiation of M cells from immature precursors in
the crypts typically takes approximately 4 days2, 84, yet the studies above suggest that some
pathogenic bacteria can achieve this within hours of exposure81-83. These characteristic
suggest that it is highly unlikely that terminally-differentiated enterocytes or crypt stem cells
could be converted by bacteria into mature M cells in such a short time-frame. A more
plausible explanation is that the bacteria produce factors which act on cells in the FAE that
are already destined to become functionally mature M cells (eg: immature, differentiating M
cells). Recent data support this hypothesis, and show how a specific factor secreted by S.
Typhimurium is used by the bacterium to enable the rapid trans-differentiation of FAE
enterocytes into M cells to permit host invasion3. Specifically, the SPI-1 encoded type III
effector protein SopB secreted by S. Typhimurium induced the epithelial-mesenchymal
transition of FAE enterocytes into M cells. This cellular trans-differentiation occurred via
the SopB-dependent activation of Wnt/β-catenin signalling and led to the induction of both
RANKL and its receptor RANK. The autocrine RANKL-RANK activation of the cells
induced the expression of Spi-B and also the epithelial-mesenchymal transition-regulating
transcription factor Slug (encoded by Snai2) that triggered the FAE enterocytes to trans-
differentiate into M cells3.
Aging impedes the functional maturation of M cells
The mucosal immune response in the intestine is significantly compromised by aging85-88.
This age-related decline in immune competence is associated with diminished antigen-
specific IgA antibody titres in the intestinal lumen86, 89 and a decreased ability to generate
tolerance to harmless antigens87. Despite the important role of M cells in mucosal immunity
in Peyer’s patches, nothing was known about how aging influenced their development and
function. Using an immunosenescent mouse model we have recently shown that there is a
dramatic decline in the functional maturation of GP2+ M cells in the Peyer’s patches of aged
mice (≥ 600 days old). Furthermore, the transcytosis of particulate antigen across the FAE
was likewise impeded38. In order to understand the mechanism underlying this aging-related
decline in M-cell status, we also examined effects on the stimuli responsible for their
induction and maturation. Aging did not affect RANKL expression by the SED stromal cells
or the initial induction of M cell differentiation, but specifically impaired the expression of
Spi-B and down-stream functional maturation of GP2+ M cells. Expression of the
chemokine CCL20 was also reduced in the FAE of aged Peyer’s patches, consistent with
data from an independent study of the effects of aging on ILFs90. As a consequence of the
impaired CCL20 expression, the attraction cells (including the “M-cell-inducing” CD11c+ B
cells37) towards the FAE was impaired. Since both the M-cell intrinsic expression of Spi-
B2, 15, 22 and CCL20-CCR6 stimulation36, 37 each play important roles in M-cell
differentiation, the effects of aging on Spi-B and CCL20 expression appear to dramatically
impede the functional maturation of M cells.
Further studies are required to determine whether this aging-related deficiency in the
mucosal immune system’s ability to sample lumenal antigens contributes to the aging-
related decline in impaired antigen-specific mucosal immune responses86. However, since
several pathogens such as S. Typhimurium75 and prions71 (as described above) exploit M
cells to invade the host, the effects of ageing on M-cell status may paradoxically also have
unexpected protective benefits. For example, the effects of aging on M-cell status may
impede the early M-cell-dependent uptake of these pathogens into the Peyer’s patches, and
in doing so significantly reduce disease susceptibility91, 92.
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M-cell-binding ligands as novel mucosal vaccine targets
The significant advances that have been made in the identification of M-cell-specific surface
markers or “immunosurveillance” receptors have focussed attention on the development
systems to specifically deliver antigens to M cells in order to improve the efficacy of
mucosal vaccines. A number of examples are discussed below. Lectins: The lectin UEA-1
binds to sites of α-1,2 fucosylation on the surfaces of M cells with high-affinity. Initial
attempts using UEA-1 to target antigen to M cells showed that such approaches were
effective in inducing antigen-specific mucosal IgA responses93-96. Along a similar theme,
oral vaccination with antigen-encapsulated liposomes coupled to UEA-1 (termed lectinized
liposomes) also led to increased uptake by Peyer’s patch M cells and the induction of higher
antigen specific secretory IgA responses97.
Alternative approaches to target antigens to the α(1,2)-fucose-containing carbohydrate
moiety on M cells have also been explored, for example, by using the non-toxic, small
molecular UEA-1 mimetic, tetragalloyl-D-lysine dendrimer98. The mAb NKM 16-2-4
specifically recognises the α(1,2)-fucose-containing carbohydrate moiety on M cells with a
greater affinity than that of UEA-1. Oral vaccine formulations comprising antigen coupled
to mAb NKM 16-2-4 (with cholera toxin as a mucosal adjuvant) have been shown to be
effective in inducing high antigen-specific mucosal IgA responses. Furthermore, oral
vaccination with botulinum toxin-conjugated mAb NKM 16-2-4 induced protective
immunity against oral exposure to a lethal toxin dose29.
Claudin 4—Although claudin 4 is a component of tight junctions, this protein may also be
redistributed to the cytoplasm of M cells and play a role in endocytosis. A peptide derived
from the c-terminal domain of the Clostridium perfringens enterotoxin binds to the external
domain of claudin 4 and can mediate uptake by M cells in vivo99, 100. Furthermore, this
claudin 4-binding peptide when coupled to antigen is effective in enhancing mucosal
antigen-specific secretory IgA responses after intranasal immunization100.
C5aR ligands—As described above, the M-cell ligand “Co1” shared high sequence
homology with OmpH of Y. enterocolitica, and each of these peptides appeared to bind to a
C5aR on the apical surface of M cells54. The conjugation of antigens to either Co1 or OmpH
could mediate their delivery to M cells in Peyer’s patches and induce enhanced mucosal
immune responses after oral administration53, 54.
Reovirus hemagglutinin protein σ1—DNA vaccines have also been shown to confer
protective immunity against a range of pathogenic microrganisms, but this approach has
proved to be poor at inducing mucosal immunity. M-cell targeting has also been explored to
attempt to improve the efficiency of the delivery of a DNA vaccine to a mucosal inductive
tissue. Since reovirus is considered to bind M cells in vivo79, a recombinant reovirus
hemagglutinin protein σ1 conjugated to polylysine was used to target a DNA vaccine to
NALT M cells101. Intranasal immunization with protein σ1-polylysine-DNA was effective
in inducing prolonged antigen-specific mucosal IgA responses, illustrating that M-cell
targeted peptide or DNA vaccinations may each represent effective means of inducing
antigen-specific mucosal immunity.
However, in addition to their role in the induction of specific mucosal immunity, M cells
may also be involved in the induction of oral tolerance. Independent studies show that
mucosal administration of low doses of reovirus protein σ1 conjugated to ovalbumin (OVA)
induced systemic unresponsiveness and failed to elicit an OVA-specific mucosal immune
response. Under these conditions the mice were shown to be tolerogenic to OVA and were
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resistant to peripheral challenge due to the generation of antigen-specific regulatory T
cells102, 103.
Concluding remarks
Significant recent advances have been made in the identification of M-cell-specific surface
markers, and the characterization of the range of pathogen-derived ligands these
“immunosurveillance” receptors can bind. By using similar approaches to those described
above it may be possible to significantly improve the efficacy and specificity of the M-cell
targeting and elicit long-lived and protective mucosal immunity, or tolerance. The
identification of the molecular mechanisms that some pathogens use to exploit M cells to
invade the host may also lead to the development of specific strategies to block the initial
host colonisation. While the targeted delivery of vaccine antigens to M cells offers potential
as an effective means of inducing antigen-specific mucosal immune responses, the
observation that the functional maturation of M cells is dramatically impaired in aged mice
implies that these strategies may be much less effective when used to immunize the
elderly38. An understanding of the molecular mechanism that underpins this aging-related
decline in M cell status will help identify novel approaches to stimulate M cell
differentiation and potentially improve mucosal immunity in the elderly.
The use of various M-cell-deficient mouse models has greatly improved our understanding
of the immunobiology of M cells in immunity and disease pathogenesis in vivo. However, in
many of these instances the possibility that M-cell-independent factors significantly
contribute to the effects described cannot be entirely excluded. For example, RANKL-
neutralization dramatically depletes M cells in the FAE in vivo20. However, RANKL may
influence gene expression by other cells in the FAE13 which may also play a role in the
uptake of lumenal antigens104. Similarly, the maturation of M cells is impaired in the FAE
of CCR6−/− mice36-38, but effects on mucosal immunity or disease susceptibility due to the
reduced size of their Peyer’s patches or defective T-cell responses cannot be entirely
excluded. The independent demonstrations that expression of the transcription factor Spi-B
is critical for the functional maturation of M cells2, 15, 22 has identified the Spi-B−/− mouse
as an alternative approach to study the immunobiology of M cells. However, Spi-B also
plays an important roles in the differentiation of plasmacytoid DC and B cells105, 106. In
order to completely avoid these off-target effects conditional knockout mice with genes
encoding RANK or Spi-B specifically-ablated in the intestinal epithelium are crucial to
study mucosal immunity in the specific absence of M cells.
An in vitro M-cell-like model system in which a monolayer of the differentiated human
enterocyte cell line Caco-2 is cultivated with B cells has been widely used to study M
cells32. However, although these cells display efficient transcytotic activity in contrast to the
undifferentiated enterocytes, it is uncertain whether these co-cultivated epithelial cells
accurately represent the many characteristics of M cells in vivo. Furthermore, analysis of the
genes expressed by “M-cell induced” Caco-2 cells shows that while they express CCL20
highly, they lack expression of many mature M cell marker genes such as GP2 and SPIB
(Table 1). Recently, exciting progress was reported on the development of a novel,
potentially physiologically relevant in vitro M-cell model system. In this system, RANKL-
stimulation induces M-cell differentiation in gut organoid cultures established from
intestinal crypts or single Lgr5+ crypt stem cells15. As well as exhibiting high transcytotic
activity, the range of genes expressed by these organoid cultures closely resembles those of
M cells in vivo (Table 1). These M-cell containing organoid cultures offer a simple and
physiologically relevant in vitro model system in which to study the immunobiology of M
cells from a range of mammalian species.
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Finally, many studies have primarily focussed on M cells as the main sites of antigen
sampling in mucosal epithelia, but several studies are challenging the assertion that this
activity is so restricted (Figure 4). Data from the ultrastructural analysis of Peyer’s patches
identified a novel, previously unrecognised, potentially important component of the normal
machinery for antigen sampling in the GALT. This study suggested that FAE enterocytes
can also acquire certain gut lumenal antigens, and exocytose the intravascular contents of
their large late endosomes into the extracellular space of the SED where they are acquired
by MNP104. Goblet cells are situated throughout mucosal epithelia and until recently were
mainly considered to function as mucin secreting cells. However, an elegant study shows
that intestinal goblet cells can also function as passages for the delivery of low molecular
weight soluble antigens to CD103+ MNP in the lamina propria107. The sampling of lumenal
antigens may also not be entirely restricted to epithelial cell populations. Although the
incidence is rare in the steady-state, certain inflammatory stimuli appear to recruit MNP
from the lamina propria to the gut epithelium where they insert their dendrites through the
tight junctions between enterocytes to directly sample the luminal contents108, 109. In
addition to this “periscoping” activity, another study has even proposed that MNP sample
lumenal antigens by extending their dendrites directly through “transcellular pores” in the M
cells themselves7.
The precise immunological consequences of these alternative antigen sampling mechanisms
are uncertain and require further analysis. Unlike macrophages which rapidly phagocytose
microorganisms and destroy them in their phagosomes, classical DC appear to be equipped
with both degradative and nondegradative antigen uptake pathways to facilitate antigen
presentation to both T and B cells110, 111. Indeed, classical DC can capture and retain
unprocessed antigen in vitro and in vivo and can transfer this antigen to naïve B cells to
initiate a specific antibody response112. Viable commensal bacteria and unprocessed antigen
can also be recovered from classical DC migrating within afferent mesenteric lymph113, 114.
These contrasting characteristics raise the question of whether the cells through which
antigens are initially sampled across the intestinal epithelium (M cells, enterocytes, goblet
cells), determine whether lumen antigens are initially transferred directly into Peyer’s
patches (such as after M-cell-mediated transcytosis) or into villi and onwards to the
mesenteric lymph nodes. Similarly, it is also plausible that in the steady-state these routes
also direct lumenal antigens to specific MNP populations, and as a consequence,
fundamentally influence the nature of the immune response directed to those antigens.
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Figure 1.
The morphological features of M cells. (a) Cartoon illustrating the morphological features of
M cells. Note the lack of microvilli and basolateral pocket containing a mononuclear
phagocyte and a lymphocyte. (b) Whole-mount immunohistochemical analysis of GP2+
mature M cells (green) in the FAE of a mouse Peyer’s patch. Note the regular distribution of
the M cells across the FAE. Note also that in the steady-state M cells are restricted to the
FAE and are mostly absent from the surrounding villi. Tissue counterstained to detect f-actin
(blue). V, villi. (c) Scanning electron micrograph of the apical surface of a M-cell. Note
characteristic lack of/blunted microvilli.
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Figure 2.
M cells differentiate from Lgr5+ stem cells in the crypts in a RANKL- and Spi-B dependent
manner. (a, 1) All epithelial cell lineages, including M cells, develop from Lgr5+ intestinal
epithelial stem cells within the crypts15. (a, 2) In the intestine RANKL is selectively
expressed by the subepithelial stromal cells beneath the FAE18, 19. RANKL controls the
differentiation of Lgr5+ stem cell-derived RANK-expressing enterocytes, into M cells15, 20.
(a, 3) RANKL also induces the expression of the ETS family transcription factor Spi-B2.
The subsequent differentiation of the ANXA5+, MARCKS-like protein 1+ immature M cells
into functionally mature GP2+, TNFAIP2+ and CCL9+ M cells is regulated by intrinsic
expression of Spi-B2, 15, 22. (a, 4) The chemokine CCL20 is specifically expressed by the
FAE34, and in Peyer’s patches it mediates the chemoattraction of CCR6-expressing
lymphocytes and leukocytes towards the FAE35. When CCL20-CCR6 signalling is impeded,
M-cell maturation is likewise impeded36-38. Data suggest that a unique subset of
CCR6hiCD11cint B cells specifically migrates towards FAE-derived CCL20 and promotes
M-cell differentiation37. However, since M-cell maturation can be induced in an in vitro
“gut organoid” model system containing only epithelial cell elements15, it plausible that
these CCL20-CCR6-mediated lympho-epithelial interactions most likely provide accessory
factors that enhance M-cell differentiation. (b) Immunohistochemical analysis of the
distribution of RANKL (green, left-hand panel), ANXA5, GP2 (green and red, respectively,
upper-middle panel), Spi-B (green, lower-middle panel) and CCL20 (red, right-hand panel)
in mouse Peyer’s patches. Dotted lines indicate the boundary of the FAE. Arrows indicate
positively immunostained M cells. V, villi.
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Figure 3.
Retrospective comparison of chemokine gene expression by M cells and the FAE. (a) Heat
map showing the mean expression of profile of multiple chemokine-encoding probe sets in
samples of Peyer’s patch (PP) M cells, cholera-toxin-induced (CT-stim.) villous M cells and
ileum intestinal epithelial cells (GSE7838)25, FAE and M cells26 and ileum (GSE13908)68.
These data were performed on Affymetrix MOE430_2 mouse genome expression arrays.
Each column represents the mean probe set intensity (log2) for all samples from each source
(n = 2-4). Significant differences between groups were sought by ANOVA. P values for
those genes which were expressed significantly (P < 0.05) within the FAE and by M cells at
levels > 2.0 fold when compared to the villous epithelium are indicated. (b) Effect of
RANKL-stimulation on the expression of chemokine-encoding genes in the villous
epithelium. These data (GSE37861)2 were performed on Affymetrix mouse gene 1.0 ST
expression arrays (equivalent chemokine-related probe sets are shown). Each column
represents the mean probe set intensity (log2) for all samples from each source (n = 3). P
values for those genes which were significantly upregulated > 2.0 fold at d 3 after RANKL-
treatments when compared to controls (d 0) are indicated. Representative probe set are
shown when multiple probe sets for a gene were present on the arrays. NS, not significant.
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Figure 4.
Potential routes of lumenal antigen sampling in the intestine by epithelial cell subsets and
MNP. (1) Sampling of gut lumenal microorganisms and macromolecules via M-cell-
mediated transcytosis. (2) Although the incidence is rare in the steady-state, certain
inflammatory stimuli appear to recruit MNP from the lamina propria where they insert their
dendrites through the tight junctions between enterocytes to directly sample the luminal
contents108, 109. (3) Another study has reported that MNP may even sample lumenal
antigens by extending their dendrites directly through “transcellular pores” in the M cells
themselves7. (4) Mucin secreting goblet cells can also function as passages for the delivery
of low molecular weight soluble antigens to CD103+ MNP in the lamina propria107. (5)
Ultrastructural analysis suggests that FAE enterocytes can also acquire certain gut lumenal
antigens, and exocytose the intravascular contents of their large late endosomes into the
extracellular space of the SED where they are acquired by MNP104.
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Table 1
Comparison of M-cell-related genes expressed in the villous epithelium in response to RANKL-stimulation,
RANKL-stimulated in vitro intestinal organoids and in vitro M-cell-like differentiated Caco-2 cells.
Gene symbol Gene title Up-regulated
in villous
epithelium by
RANKL
(Fold
Change)a
Day of
peak
expression
level
Up-regulated
in small
intestinal
organoids by
RANKL in
vitro
(Fold
Change)b
Up-regulated
in M-cell-like
cells in vitro
(Fold
Change)c
Gp2 glycoprotein 2
(zymogen
granule
membrane)
46.9 3 56.5 Not
expressed
Spib Spi-B
transcription
factor (Spi-
1/PU.1 related)
31.9 2 18.5 Not
expressed
Anxa5 annexin A5 12.7 2 35.5 Unchanged
Ccl20 chemokine (C-C
motif) ligand 20
11.3 2 158.8 8
Tnfaip2 tumor necrosis
factor, alpha-
induced protein
2 (M-Sec)
7.7 2 13.9 Unchanged
Ccl9 chemokine (C-C
motif) ligand 9
4.9 2 32.0 n/a
Prnp prion protein 3.7 2 60.2 Unchanged
Marcksl1 MARCKS-like 1 3.6 1 7.0 Unchanged
a
These data (GSE37861)2 were performed on Affymetrix mouse gene 1.0 ST expression arrays. Fold-change in gene expression level at peak day
when compared to controls (d 0).
b
These data were performed on Agilent 4x44K whole mouse genome expression arrays and equivalent gene probe sets were compared
(GSE38785)15. Fold-change in gene expression when compared to unstimulated control organoids.
c
Performed on Affymetrix human genome U133 plus 2 expression arrays and equivalent gene probe sets were compared. Fold-change in gene
expression by M-cell-like differentiated Caco-2 cells when compared to undifferentiated controls (GSE25330, GSE7745)115. n/a; an equivalent
annotated probe set was not present on the array.
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